Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
This study has been completed.
Study NCT00422214   Information provided by AstraZeneca
First Received: January 12, 2007   Last Updated: March 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Affective Psychosis, Bipolar
Depression, Bipolar
Manic-Depressive Psychosis
Psychoses, Manic-Depressive
Additional conditions recognized in this trial
Affective Disorders, Psychotic
Bipolar Disorder
Depression
Depressive Disorder
Depressive Disorder, Major
Psychotic Disorders
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Quetiapine fumarate (Seroquel) SR
Additional drug interventions recognized in this trial
Quetiapine
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services